论文部分内容阅读
自2001年6月-2006年6月,我们用尿激酶静脉溶栓治疗50例脑栓塞与50例急性脑梗死患者,对其疗效及安全性进行对比。现报告如下。1临床资料1．1一般资料本文50例脑栓塞患者(A组),男30例,女20例,年龄40-76岁;平均年龄60．5岁。急性脑梗死患者(B组),男31例,女19例,年龄42-78岁;平均62．4岁。A组均有房颤史,其中风湿性心脏病10例,冠心病31例,均未长期服用抗凝剂,口服阿司匹林15例。B组口服阿司匹林15例。两组病例均符合2006年全国急性脑血管病治疗指南
From June 2001 to June 2006, we treated 50 patients with cerebral embolism and 50 patients with acute cerebral infarction with urokinase intravenous thrombolysis, and compared their efficacy and safety. The report is as follows. 1 Clinical data 1.1 General Information 50 cases of cerebral embolism patients (A group), 30 males and 20 females, aged 40-76 years; mean age 60.5 years old. Patients with acute cerebral infarction (group B), 31 males and 19 females, aged 42-78 years; mean 62.4 years old. A group had a history of atrial fibrillation, including 10 cases of rheumatic heart disease, coronary heart disease in 31 cases, no long-term use of anticoagulants, oral aspirin in 15 cases. Group B oral aspirin in 15 cases. Two groups of patients are in line with the 2006 national guidelines for the treatment of acute cerebrovascular disease